HIV infection is persistent in the CNS, to evaluate the compartmentalization of the CNS immune response to HIV, we compared soluble markers of cellular immunity in the blood and CSF among HIV− (n = 19) and HIV+ (n = 68), as well as among HIV participants with or without CSF pleocytosis. Dysfunction of the blood cerebrospinal fluid barrier (BCSFB) was common in HIV participants. CSF levels of TNFα, IFNγ, IL-2, IL-6, IL-7, IL-10, IP-10, MIP-1α, MIP-1β, and RANTES were significantly higher in participants with CSF pleocytosis (P b 0.05); serum levels of these biomarkers were comparable. The CNS immune response is compartmentalized, and remains so despite the BCSFB dysfunction during HIV infection; it is markedly reduced by virology suppression, although BCSFB dysfunction persists on this subgroup.
Introduction
The CNS barriers, i.e. blood-brain barrier (BBB) and the blood-CSF barrier (BCSFB) are highly selective physiological barriers that restrict the passage of macromolecules from circulating blood to the CNS. These barriers protect neurons from constant changes in the concentration of blood constituents without restricting the transport of nutrients and metabolic products to and from the brain, respectively, as well as the bi-directional communication with the immune system (de Vries et al., 1997; Ballabh et al., 2004; Hamilton et al., 2007; Stamatovic et al., 2008; Abbott et al., 2010; Banks, 2015) . Reductions in CSF production, release, and flow rate impair the BCSFB function, thereby increasing the ratio of CSF albumin to serum albumin (albumin quotient Q Alb ) (Kuehne et al., 2013) .
In recent years, there has been a resurgence of interest in the physiology of the brain barriers, which may play critical roles in a wide range of neurological disorders, including those associated with HIV infection (Saunders et al., 2008) . Studies conducted prior to the development of highly active anti-retroviral therapy demonstrated that dysfunction of the BCSFB was common in HIV participants, particularly in those with increased CSF white blood cell (WBC) count (pleocytosis) (Marshall et al., 1988; Petito and Cash, 1992) . More recent studies also found evidence of BCSFB dysfunction (Andersson et al., 2001; Calcagno et al., 2014) , which can occur early in infection, and persist even with highly active anti-retroviral therapy (Calcagno et al., 2015) .
HIV is a systemic infection, of which the nervous system is an important component (Brew et al., 1997) . Indeed, HIV is highly neurotropic and neurovirulent, and causes persistent infection in the CNS. Invasion of the CNS during acute HIV infection (Resnick et al., 1988; Spudich et al., 2011; Valcour et al., 2013) initiates an inflammatory cascade that eventually compartmentalizes the CNS immune response even with anti-retroviral therapy. Thus we hypothesize that the inflammatory response in HIV infection is stronger in CNS than peripheral blood, characterizing compartmentalization of CNS cellular immune response; despite the dysfunction of the BCSFB during HIV infection. By compartmentalization of immune responses we mean evidence of immune activity, including production of signaling molecules such as chemokines and interleukins, that is CNS specific and would be missed by studying only plasma or serum. 
